(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

APOBIOLOGIX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

APOBIOLOGIX

ST13

US500000086634783

Class

5, 42

Filing

86634783

Registration

5169202

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

56

Latest update

06/30/2026

Trademark type

Combined

Nice classes

5, 42

Filing date

05/19/2015

Registration date

03/28/2017

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/08/2026

Last transaction

06/30/2026

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

Drawing code

3

Owner type

03

Owner location

TORONTO, CA

Examiner

JAGANNATHAN, SIDDHARTH

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of a generally octagonal grouping of circles and semicircles to the left of a stylized rendering of the word "Apobiologix" with the letter "A" presented as a capital letter and the remaining letters presented in lower case lettering.

Holders and representatives

Holders

APOTEX INC.
Apotex Technologies Inc.

Representatives

Jessica G. Kraver Katten Muchin Rosenman LLP

Technical classification

Nice Classes

Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparationsprescription drugsgeneric drugsbiosimilar drugs for hemopoetic *hematopoietic* growth factors used for stimulating white blood cell productionfor the treatment of proliferative disordersangiogenic disorders including cancer

Class 42

Drug product research development services

Publications

History of USPTO decisions and trademark events.

56 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

06/08/2026

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

06/08/2026

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

06/08/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/01/2026

E89R

TEAS SECTION 8 & 9 RECEIVED

03/31/2026

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

03/28/2026

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

03/08/2024

C15P

REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

03/08/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/08/2024

E815

TEAS SECTION 8 & 15 RECEIVED

09/18/2023

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

07/19/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/19/2023

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

07/19/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/19/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/19/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/19/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/19/2023

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

03/28/2022

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

06/19/2019

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

06/28/2017

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/26/2017

ES7R

TEAS SECTION 7 REQUEST RECEIVED

04/21/2017

R.PR

REGISTERED-PRINCIPAL REGISTER

03/28/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/10/2017

PUBO

PUBLISHED FOR OPPOSITION

01/10/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/21/2016

OTHE

CASE RETURNED TO EXAMINATION

12/06/2016

IUCN

NOTICE OF ALLOWANCE CANCELLED

12/06/2016

PCBG

PETITION TO DIRECTOR - CHANGE BASIS - GRANTED

11/18/2016

TPDR

TEAS PETITION TO DIRECTOR RECEIVED

11/04/2016

PILM

PETITION INQUIRY LETTER ISSUED

10/28/2016

APET

ASSIGNED TO PETITION STAFF

10/27/2016

44EP

44(e) PETITION - RECEIVED

10/27/2016

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

10/24/2016

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

10/06/2016

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

08/18/2016

EX1G

SOU EXTENSION 1 GRANTED

08/16/2016

EXT1

SOU EXTENSION 1 FILED

08/16/2016

EEXT

SOU TEAS EXTENSION RECEIVED

08/16/2016

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

02/16/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/22/2015

PUBO

PUBLISHED FOR OPPOSITION

12/22/2015

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/02/2015

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

11/19/2015

ALIE

ASSIGNED TO LIE

11/19/2015

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/06/2015

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/06/2015

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/05/2015

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/05/2015

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/31/2015

GNRT

NON-FINAL ACTION E-MAILED

08/31/2015

CNRT

NON-FINAL ACTION WRITTEN

08/31/2015

DOCK

ASSIGNED TO EXAMINER

08/31/2015

MDSM

NOTICE OF DESIGN SEARCH CODE E-MAILED

05/29/2015

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/28/2015

NWAP

NEW APPLICATION ENTERED

05/22/2015

Continuous trademark protection

Get notified about every new filing that threatens APOBIOLOGIX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.